Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Prevalence of Anemia and Iron Deficiency in Pediatric Patients on Ventricular Assist Devices
Kriti Puri1, Aamir Jeewa1, Iki Adachi2
1From the Section of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Insights
Anemia and iron deficiency are common in pediatric ventricular assist device (VAD) patients. Pulsatile VAD use is linked to worsening anemia during support, necessitating specific iron testing.
Area of Science:
- Pediatric cardiology
- Hematology
- Medical devices
Background:
- Anemia and iron deficiency are common in children requiring ventricular assist devices (VADs).
- Understanding these conditions in pediatric VAD patients is crucial for effective management.
Purpose of the Study:
- To determine the prevalence and characteristics of anemia and iron deficiency in pediatric VAD patients.
- To compare these indices between pulsatile VAD (P-VAD) and continuous-flow VAD (CF-VAD) support.
Main Methods:
- Retrospective review of pediatric patients (<21 years) on durable VAD support for ≥7 days.
- Evaluation of red blood cell (RBC) and iron deficiency indices at VAD implant and explant.
- Comparison of anemia and iron deficiency between P-VAD and CF-VAD groups.
Main Results:
- 48% of patients were anemic at VAD implant; 67% of CF-VAD patients had anemia versus 34% of P-VAD patients.
- Iron deficiency was present in 52% of patients at implant, with similar prevalence in both VAD types.
- Anemia prevalence increased to 71% at explant, with higher RBC transfusion volumes in P-VAD patients.
Conclusions:
- Anemia and iron deficiency are prevalent in pediatric VAD patients.
- Pulsatile VAD patients may develop anemia during VAD support.
- High RBC transfusion rates can mask microcytosis, highlighting the need for specific iron studies to diagnose iron deficiency.
Abstract:
The prevalence and characteristics of anemia and iron deficiency in children supported by a ventricular assist device (VAD) are unknown. Patients <21 years of age on durable VAD support for ≥7 days at Texas Children's Hospital from 2006 to 2015 were retrospectively reviewed. Red blood cell (RBC) and iron deficiency indices in pulsatile VAD (P-VAD) and continuous-flow VAD (CF-VAD) were evaluated. Anemia, iron deficiency, and iron therapy regimens were identified. Seventy-six VAD implants in 74 patients were included: 45 P-VAD and 31 CF-VAD. Overall, 48% (36/75) of patients were anemic at VAD implant, with 67% of CF-VAD and 34% of P-VAD affected. Iron deficiency was seen in 52% (39/75) of patients at implant (similar in both groups). At explant, 71% (53/75) had anemia (similar in both groups). No patients had microcytosis. Iron supplementation was given to 20 patients, with four receiving target replacement therapy (2-6 mg/kg/d × 90 days). Red blood cell transfusion volumes were higher for P-VAD versus CF-VAD. We concluded that anemia and iron deficiency are common in pediatric VAD patients. Pulsatile VAD patients tend to develop anemia over the course of VAD support. Lack of microcytosis, likely masked by high RBC transfusions, suggests that specific iron studies are necessary to identify iron deficiency.
More Related Videos
05:18Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Hemodialysis II: Procedure and Complications